प्रकाश का उपयोग करके रोगाणुओं में एंजाइम प्रतिक्रियाओं को तेज करना

The emergence of photobiocatalysis represents a significant inflection point in industrial biomanufacturing, moving beyond conventional chemical synthesis. This innovative approach, leveraging light to accelerate enzyme reactions within engineered microbes, offers a compelling pathway for the cost-effective and environmentally benign production of high-value compounds. India, with its robust biotechnology sector and a pressing need for sustainable industrial solutions, must strategically invest in this domain.

Historically, our pharmaceutical and chemical industries have relied heavily on energy-intensive, multi-step chemical processes, often generating substantial hazardous waste. This new paradigm, exemplified by the production of anti-cancer drugs like vinblastine and industrial polymers from simple sugars using E. coli, promises to drastically reduce the environmental footprint. It aligns with the national imperative for Green Chemistry and a circular economy, as outlined in various policy documents from the NITI Aayog and the Ministry of Environment, Forest and Climate Change.

However, scaling these laboratory successes to industrial production presents formidable challenges. While the article highlights the potential for 'large-scale chemical production,' issues of bioreactor design, light penetration efficiency in dense cultures, and downstream processing remain critical. Furthermore, regulatory frameworks for genetically engineered microbes, though established by bodies like the Genetic Engineering Appraisal Committee (GEAC), need to be agile enough to facilitate innovation while ensuring biosafety.

To capitalize on this, the Department of Biotechnology (DBT) and the Department of Science & Technology (DST) must prioritize funding for translational research and pilot projects. Establishing dedicated bio-manufacturing hubs, similar to those in Singapore or Germany, could foster collaboration between academia and industry. This would not only secure domestic supply chains for critical drugs but also position India as a leader in sustainable bio-manufacturing, attracting global investment and talent.